Matinas BioPharma

Matinas BioPharma | 1,170 followers on LinkedIn. Matinas is focused on improving the intracellular delivery of critical therapeutics through its LNC delivery platform and is developing its own portfolio of products and partnering with leading pharma companies to develop new formulations that take full advantage of the LNC platform. Preclinical & clinical data have shown this novel tech can provide solutions to many of the challenges in achieving safe & effective intracellular delivery, for both small & larger, more complex molecules. The combination of a unique MoA and flexibility in the formulation and route of administration, position our LNC tech to potentially become the preferred next-gen intracellular drug delivery vehicle and an improvement over lipid nanoparticles and viral vectors.